The Potentiating Effect of GLP-1 on Glucose-induced Glucagon Suppression in Healthy Individuals and in Patients with Type 1 and 2 Diabetes

被引：0
|
作者：
Bagger, Jonatan I.
Lund, Asger
Grondahl, Magnus
Holst, Jens J.
Vilsboll, Tina
Knop, Filip K.
机构：
来源：
DIABETES | 2016年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1890-P
引用
收藏
页码：A487 / A487
页数：1
相关论文
共 50 条
  • [31] Additive effects of GLP-1 and pioglitazone in patients with type 2 diabetes
    Zander, M
    Christiansen, A
    Madsbad, S
    Holst, JJ
    DIABETES, 2004, 53 : A342 - A342
  • [32] GLP-1 as a Therapeutic Agent in Patients with Type 2 Diabetes Mellitus
    Legakis, Ioannis
    RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY, 2007, 1 (03) : 193 - 201
  • [33] GLP-1 RA and Risk of Malignancy in Patients with Type 2 Diabetes
    Ishola, Faidat A.
    Pike, C. William
    Kim, Sun H.
    DIABETES, 2024, 73
  • [34] Synaptotagmin-7 is a positive regulator of glucose-induced GLP-1 secretion
    Gustavsson, N.
    Wang, Y.
    Kang, Y.
    Han, W.
    DIABETOLOGIA, 2010, 53 : S15 - S15
  • [35] Combining GLP-1 and glucagon for the treatment of obesity and diabetes
    Idris, Iskandar
    DIABETES OBESITY & METABOLISM, 2013, 15 (05): : 481 - 482
  • [36] The role of cholecystokinin (CCK) and glucagon-like peptide-1 (GLP-1) in glucose-induced ileal brake in conscious rats
    Bozkurt, A
    Deniz, M
    Imeryuz, N
    Ulusoy, NB
    Yegen, BC
    GASTROENTEROLOGY, 2001, 120 (05) : A74 - A74
  • [37] Glucose-induced cAMP elevation in β-cells involves amplification of constitutive and glucagon-activated GLP-1 receptor signalling
    Shuai, Hongyan
    Xu, Yunjian
    Ahooghalandari, Parvin
    Tengholm, Anders
    ACTA PHYSIOLOGICA, 2021, 231 (04)
  • [38] Mechanisms Controlling Glucose-Induced GLP-1 Secretion in Human Small Intestine
    Sun, Emily W.
    de Fontgalland, Dayan
    Rabbitt, Philippa
    Hollington, Paul
    Sposato, Luigi
    Due, Steven L.
    Wattchow, David A.
    Rayner, Christopher K.
    Deane, Adam M.
    Young, Richard L.
    Keating, Damien J.
    DIABETES, 2017, 66 (08) : 2144 - 2149
  • [39] Clinical Outcomes of Tirzepatide or GLP-1 Receptor Agonists in Individuals With Type 2 Diabetes
    Chuang, Min-Hsiang
    Chen, Jui-Yi
    Wang, Hsien-Yi
    Jiang, Zheng-Hong
    Wu, Vin-Cent
    JAMA NETWORK OPEN, 2024, 7 (08)
  • [40] GLP-1 receptor agonists for type 2 diabetes
    De Block, Christophe E. M.
    Van Gaal, Luc F.
    LANCET, 2009, 374 (9683): : 4 - 6
12345